Skip to main content

Table 4 Frequency of potential vocal health hazards and general medical comorbidities among all studied population

From: A comparative study of the voice-related quality of life among Egyptian elderly with and without voice complaints

 

Elderly group

P value

With voice complaints

Without voice complaints

Count

Row, N %

Count

Row, N %

Professionalism

Professional

16

64.0%

9

36.0%

0.084

Non-professional

27

43.5%

35

56.5%

Retirement

Retired

37

48.7%

39

51.3%

0.716

Non-retired

6

54.5%

5

45.5%

Abuse of voice

Present

22

78.6%

6

21.4%

< 0.001

Absent

21

35.6%

38

64.4%

Smoking

No

18

45.0%

22

55.0%

0.396

light

6

40.0%

9

60.0%

Heavy

18

62.1%

11

37.9%

Ex-smoker

1

33.3%

2

66.7%

Temperament

Quiet

11

57.9%

8

42.1%

0.404

Tense

32

47.1%

36

52.9%

Repeated URTIs

Present

2

22.2%

7

77.8%

0.157

Absent

41

52.6%

37

47.4%

Allergy

Present

1

16.7%

5

83.3%

0.202

Absent

42

51.9%

39

48.1%

Rheumatoid symptoms

Present

2

40.0%

3

60.0%

1.000

Absent

41

50.0%

41

50.0%

Chronic cough

Present

15

68.2%

7

31.8%

< 0.001

Absent

28

43.1%

37

56.9%

Breathing problems

Present

5

62.5%

3

37.5%

0.484

Absent

38

48.1%

41

51.9%

Swallowing problems

Present

12

48.0%

13

52.0%

0.866

Absent

31

50.0%

31

50.0%

Reflux symptoms

Present

11

45.8%

13

54.2%

0.679

Absent

32

50.8%

31

49.2%

Medications

Present

20

45.5%

24

54.5%

0.454

Absent

23

53.5%

20

46.5%

Medications

Anti- rheumatic

2

40.0%

3

60.0%

0.148

Anti-reflux

3

23.1%

10

76.9%

Steroids

2

100.0%

0

0.0%

Anti-reflux, DM-HTN diuretics, steroids

0

0.0%

2

100.0%

DM-HTN diuretics, anti-reflux

1

100.0%

0

0.0%

DM-HTN diuretics

5

45.5%

6

54.5%

HTN ACI

1

50.0%

1

50.0%

HTN diuretics, anti-reflux

2

66.7%

1

33.3%

HTN diuretics

0

0.0%

1

100.0%

Mucolytic

1

100.0%

0

0.0%

Steroids, anti-reflux

3

100.0%

0

0.0%

  1. ACI angiotensinogen converting enzymes inhibitors, DM diabetes mellitus